Catabasis Pharma prices $10M equity offering

|About: Catabasis Pharmaceuticals (CATB)|By:, SA News Editor

Catabasis Pharmaceuticals (NASDAQ:CATB) prices its public offering of 2.5M shares of common stock at $4. Underwriters over-allotment is an additional 375K shares. Closing date is September 28.

Net proceeds will fund ongoing and planned clinical trials of edasalonexent (CAT-1004), working capital and general corporate purposes.

Today's close was $4.36.

Subscribe for full text news in your inbox